- Report
- September 2024
- 110 Pages
Global
From €3500EUR$4,120USD£3,106GBP
Dermatan Sulfate is a type of hematological drug used to treat a variety of conditions, including thrombosis, pulmonary embolism, and deep vein thrombosis. It is a glycosaminoglycan, a type of carbohydrate molecule, and is composed of repeating disaccharide units of glucuronic acid and N-acetylgalactosamine. Dermatan Sulfate is produced by the body and is found in the skin, blood vessels, and other connective tissues. It is also used in the treatment of certain types of cancer, such as ovarian cancer.
Dermatan Sulfate is available in both oral and injectable forms. It is typically administered in combination with other drugs, such as anticoagulants, to reduce the risk of clotting. The drug is also used to reduce inflammation and improve wound healing.
The Dermatan Sulfate market is highly competitive, with a number of companies offering products for the treatment of various conditions. Some of the major players in the market include Pfizer, Merck, Sanofi, Bristol-Myers Squibb, and Novartis. Show Less Read more